Patient CenterMore>
Yong LiuProf.
Chief Scientist
Online Inquiry
Shu Yongqianprofessor
Director of Oncology Department, Jiangsu Provincia
Online Inquiry
Xia Jianchuanprofessor
Director of Biotherapy Center, Director of Somatic
Online Inquiry
Ask The Experts
EventsMore>
08-08 2017
The first multi-center clinical study in the field of ACTL and TKI treatment of lung cancer continues to recruit!
Is my condition suitable for ACTL immunotherapy?
ACTL immunotherapy is effective in advanced, metastatic and recurrent cancer. Early intervention and combination with other therapies bring a better outcome.

Diagnosis Report Query & Download

Case Studies